Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Asthma-III: Symptoms and Complications

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

Asthma-I: Introduction

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-II: Pathophysiology and Classification

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Antiasthma Drugs: β2-Adrenoceptor Agonists

Antiasthma Drugs: β₂-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An Unusual Case of Ischemic Stroke.

Journal of cardiovascular echography·2026

Same author

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026

Same author

Unburdening healthcare systems through telenursing in chronic respiratory disease management: a systematic review.

Frontiers in digital health·2026

Same author

Advances in the management of allergic rhinitis: clinical relevance of the mometasone furoate-olopatadine association and the challenge of patient self-diagnosis and self-treatment.

Drugs in context·2026

Same author

Impact of Single-Inhaler Triple Therapy FF/UMEC/VI on Disease Stability in COPD: A Real-World 12-Month Analysis.

Pulmonary therapy·2026

Same author

Sex-Based Comparison of Remission in Patients with Severe Type 2 Asthma Treated with Biologics: A Real-World Analysis from the "Southern Italy Network on Severe Asthma Therapy".

Respiration; international review of thoracic diseases·2026

Same journal

The Evaluation initiative: management of rhinitis by Italian otorhinolaryngologists.

Multidisciplinary respiratory medicine·2026

Same journal

Knowledge and attitudes toward electronic cigarettes among healthcare providers and health professional students: implications for patient counseling - A systematic review.

Multidisciplinary respiratory medicine·2026

Same journal

Splenic silicosis, a rare extrapulmonary manifestation of occupational silica exposure: A case report.

Multidisciplinary respiratory medicine·2026

Same journal

Recupera e Respira: A sustainable pilot model for disposal of inhalers.

Multidisciplinary respiratory medicine·2026

Same journal

Early alteration of single-breath nitrogen washout (ΔN₂/L) in smokers with preserved spirometry: Association with smoking burden.

Multidisciplinary respiratory medicine·2026

Same journal

Diagnosis and management of interstitial lung disease with concomitant lung cancer in Italy: Results from the ICARO clinician survey.

Multidisciplinary respiratory medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 13, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Asthma-related deaths.

Gennaro D'Amato¹, Carolina Vitale², Antonio Molino³

¹Division of Respiratory and Allergic Diseases, Department of Chest Diseases, High Speciality "A. Cardarelli" Hospital, Napoli, Italy.

Multidisciplinary Respiratory Medicine

|October 19, 2016

Summary

This summary is machine-generated.

Asthma remains a deadly disease, causing 250,000 premature deaths annually. Improving patient education and guided self-management are key to reducing asthma mortality worldwide.

Keywords:

Asthma mortality trends Asthma-deaths Inhaled corticosteroids Near fatal asthma

More Related Videos

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Related Experiment Videos

Last Updated: Mar 13, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Methodology for Sputum Induction and Laboratory Processing

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Area of Science:

Pulmonology
Public Health
Epidemiology

Background:

Despite advances in asthma treatment and guidelines, asthma mortality remains a significant global health issue, with an estimated 250,000 premature deaths annually.
Asthma mortality rates exhibit wide variations across different countries, age groups, and ethnicities, highlighting the need for tailored interventions.

Approach:

This analysis reviews identified risk factors and preventable causes contributing to asthma-related deaths.
Focuses on the role of patient education, accurate diagnosis, and appropriate treatment classification in preventing mortality.

Key Points:

Identified risk factors for asthma mortality include a history of near-fatal asthma, recent emergency care visits, inconsistent corticosteroid use, and poor adherence to treatment plans.
Preventable factors, such as inadequate patient education on risk recognition and management, diagnostic inaccuracies, and improper severity classification, are implicated in most asthma deaths.

Conclusions:

Guided self-management systems and improved patient education are crucial for enhancing asthma control and reducing preventable asthma deaths globally.
Addressing deficiencies in asthma diagnosis, severity assessment, and patient adherence is essential for mitigating worldwide asthma mortality.